OUR UNIQUE INTEGRATED DERMATOLOGY STRATEGY
We believe our unique, Integrated Dermatology Strategy is a key differentiator for Galderma by creating greater consumer, patient and healthcare professional engagement, generating better customer insights and delivering continuous innovation.
What is the Integrated Dermatology Strategy?
It is a key enabler to help us fulfill our bold ambition to be the world’s leading dermatology company.
It is a full-scale commitment to put consumers, patients and healthcare professionals at the center of everything we do.
The development of our strategy started with the realization that the dermatology market has become one of the fastest growing self-care categories. Emerging trends, such as rising disposable income, greater acceptance of aesthetic procedures and rapidly increasing consumer engagement in skin health topics on-line, were fueling rapid growth in the category.
Strategic initiatives driving our growth
Building a common integrated platform
Moving away from three separate, siloed business units – each with its own supporting functions. We integrated our three separate businesses and established one business – one Galderma – on a common platform supported by end-to-end enabling functions and an optimized manufacturing and distribution footprint.
Generating customer and consumer data insights
The ‘digitalization’ of our business has significantly increased the data we generate and the insights we obtain in terms of healthcare professional, patient and consumer trends. These insights, in turn, lead to enhanced customer focus and drive continuous innovation in response to customer needs.
Driving continuous innovation
Today, we’re approaching double-digit investment and providing critical support to key clinical assets, such as nemolizumab and RelabotulinumtoxinA - which represent potentially transformative products in their respective categories – and we continue to focus on scientific innovation within our existing portfolio.
Building the broadest portfolio of flagship brands and services in dermatology
We leverage our synergistic portfolio of flagship brands and services to drive concomitant use across Injectable Aesthetics, Dermo-cosmetics and Therapeutic Dermatology. For example, Alastin products are clinically proven to help accelerate recovery and improve results when paired with Injectable Aesthetics treatments, and Epiduo and Cetaphil Acne prone Pro line are distributed in dual packaging.
Delivering commercial excellence via our omnichannel go-to-market model
We have also significantly enhanced our digital tools and platforms. We recognized that to succeed in this fast-changing market, we need to have increased interaction with the people who use our products and with skin health ‘influencers’ online, many of whom are healthcare professionals. We have a long heritage of customer excellence and are routinely ranked #1 in customer focus by healthcare professionals.
OUR FLAGSHIP BRANDS
We offer a synergistic portfolio of flagship brands with leading market positions in their respective product categories, supported by science-based product differentiation and premium positioning.
We seek bold and sophisticated talent with the capacity to innovate, collaborate and execute across teams and geographies to deliver outstanding results, and our teams bring diverse skills, innovation and passion to their work every day.